In Brief


Clinical Roundup
Drugs & Targets
NCI Trials


NCI Trials for February 2022
The National Cancer Institute approved the following clinical research study last month.
Trending Stories
- UCSD’s Comprehensive Cancer Center designation is in trouble; director Califano steps down amid turmoil
- Richard Pazdur discusses root causes of cisplatin and carboplatin shortage and what can be done to alleviate it
- Cisplatin, carboplatin shortage prompts rationing of lifesaving drugs—patients will die
- Robert Winn tells us how he led VCU Massey to obtain Comprehensive designation
- Sexual harassers should face consequences: As NIH director, Bertagnolli can foster change
- Ezra Cohen named chief medical officer of oncology at Tempus